Skip to main content
Fig. 5 | Microbial Cell Factories

Fig. 5

From: Assessment of bacteriocin production by clinical Pseudomonas aeruginosa isolates and their potential as therapeutic agents

Fig. 5

The increase in the percentage of inhibition zone after 4 h of treatment of the Clinical isolate of P. aeruginosa with Mitomycin C. Mitomycin C, as an inducer of pyocin production, significantly boosted antibacterial peptides production by an average of 67.78%. The most substantial increase was observed in isolate C108 (100.8%), while C115 showed the smallest increase (41.77%)

Back to article page

Microbial Cell Factories

ISSN: 1475-2859

Contact us